• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problem Fluid/Blood Leak (1250)
Patient Problem Aortic Regurgitation (1716)
Event Date 11/06/2020
Event Type  Injury  
Manufacturer Narrative
The device was not returned to edwards for evaluation.Attempts to retrieve the device and additional information is in process.If additional information is received a supplemental mdr will be submitted.Regurgitation which develops progressively over time can be due to a number of issues including patient related factors or structural valve deterioration.Structural valve deterioration (svd) is the most common reason for bioprostheses explants and encompasses multiple failure modes, including calcification, non-calcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes may occur singularly or concomitantly.Regurgitation may also develop progressively if host fibrotic tissue, or pannus, grows onto the bioprosthetic valve.Pannus, a cause of nonstructural dysfunction, may interfere with functionality of the device by restricting the leaflet motion leading to abnormal coaptation.The cause of the event cannot be determined.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards received notification a aortic pericardial valve implanted in the aortic position was explanted after unknown implant duration due to two intravalvular leaks observed at tee.Patient first underwent an attempt to repair the valve with unsatisfactory result, and as reported, replacement was the best option.
 
Manufacturer Narrative
H10.Additional manufacturer narrative: the device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.H11.Corrected data: based on the additional information obtained, this event is no longer considered reportable and this correction is being submitted.
 
Event Description
It was learned the 25mm aortic pericardial valve was explanted at implant due to two intravalvular leaks observed on tee.This case involved a 51 y-o patient with a congenital bicuspid valve who first underwent an attempt to repair the valve with unsatisfactory result, and as reported, replacement was the best option.As reported, no tears were observed on the valve.Per the sales rep., it appeared that the leaks were from between the frame and the leaflet.Another 25mm valve was implanted in replacement.The patient did not suffer any injury or adverse event due to the explant at implant and was doing well after procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
MDR Report Key10925340
MDR Text Key218934916
Report Number2015691-2020-14772
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150048/S021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 11/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/20/2024
Device Model Number11500A
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/09/2020
Initial Date FDA Received12/01/2020
Supplement Dates Manufacturer Received12/17/2020
Supplement Dates FDA Received12/30/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age51 YR
-
-